Review: taking Metoprolol tartrate and Amiodarone hydrochloride together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Amiodarone hydrochloride together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Amiodarone hydrochloride. It is created by eHealthMe based on reports of 2,061 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol tartrate and Amiodarone hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 38,699 users)

Amiodarone Hydrochloride

Amiodarone hydrochloride has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. (latest outcomes from Amiodarone hydrochloride 2,613 users)

On Jul, 29, 2016

2,061 people who take Metoprolol Tartrate, Amiodarone Hydrochloride are studied.


Number of reports submitted per year:

Metoprolol tartrate and Amiodarone hydrochloride drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 33.0% - (2 of 6 people)
  • 1 - 6 months: 16.0% - (1 of 6 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 6.0% - (1 of 16 people)
  • 2 - 5 years: 50.0% - (3 of 6 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 1 people)
Amiodarone Hydrochloride:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 50.0% - (2 of 4 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 84.0% - (16 of 19 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 50.0% - (5 of 10 people)
  • male: 20.0% - (7 of 35 people)
Amiodarone Hydrochloride:
  • female: 60.0% - (6 of 10 people)
  • male: 52.0% - (18 of 34 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 8.0% - (1 of 12 people)
  • 60+: 34.0% - (11 of 32 people)
Amiodarone Hydrochloride:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (12 of 12 people)
  • 60+: 38.0% - (12 of 31 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • pain
  • injury
  • anxiety
  • emotional distress
  • fear
  • renal injury
  • death
  • anhedonia
  • multi-organ failure
1 - 6 months:
  • rhabdomyolysis
  • fatigue
  • urinary tract infection
  • dehydration
  • dyspnoea
  • asthenia
  • atrial fibrillation
  • torsade de pointes
  • atrioventricular block complete
  • bradycardia
6 - 12 months:
  • alopecia
  • anxiety
  • drug ineffective
  • dyspnoea
  • eczema
  • anhedonia
  • body temperature increased
  • brugada syndrome
  • burning sensation
  • cardiac failure
1 - 2 years:
  • lightheadedness - fainting
  • nervousness
  • shortness of breath
  • swelling of the ankles - feet - legs
  • hypotension
  • bradycardia
  • pain
  • anxiety
  • asthenia
  • deformity
2 - 5 years:
  • bradycardia
  • renal failure
  • dizziness
  • erectile dysfunction
  • angina pectoris
  • aphasia
  • drug level increased
  • dyspnoea
  • headache
  • injury
5 - 10 years:
  • erectile dysfunction
  • asthenia
  • atrioventricular block
  • blood ph decreased
  • blood ph increased
  • bradycardia
  • cardiac failure
  • concomitant disease progression
  • confusion
  • disseminated intravascular coagulation
10+ years:
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • dermatomyositis
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fungal infection
  • lack of strength, muscle weakness, weakness
  • lower blood pressure
  • muscle necrosis
  • rhabdomyolysis
  • acute respiratory failure
not specified:
  • pain
  • atrial fibrillation
  • renal failure
  • anxiety
  • injury
  • cardiac failure congestive
  • dyspnoea
  • asthenia
  • hypotension
  • emotional distress

Most common drug interactions by gender *:

female:
  • pain
  • atrial fibrillation
  • anxiety
  • cardiac failure congestive
  • injury
  • asthenia
  • renal failure
  • dyspnoea
  • renal failure acute
  • nausea
male:
  • pain
  • renal failure
  • anxiety
  • atrial fibrillation
  • injury
  • emotional distress
  • dyspnoea
  • fear
  • hypotension
  • nausea

Most common drug interactions by age *:

0-1:
  • atrial fibrillation
  • blood pressure decreased
  • dysphagia
  • glossodynia
  • lip swelling
  • pancytopenia
  • pharyngolaryngeal pain
  • white blood cell count decreased
10-19:
  • acute circulatory failure
  • hepatic necrosis
  • liver function tests nos abnormal
20-29:
  • renal failure
  • atrial fibrillation
  • cardiac failure congestive
  • mass
  • multi-organ failure
  • anhedonia
  • back pain
  • blood cholesterol increased
  • bronchitis
  • cardiogenic shock
30-39:
  • cardiogenic shock
  • confusional state
  • renal failure
  • hypotension
  • pain
  • cardiac arrest
  • anxiety
  • stress
  • dyspnoea
  • multiple drug overdose
40-49:
  • renal failure
  • pain
  • atrial fibrillation
  • arrhythmia
  • cardiac arrest
  • ventricular fibrillation
  • anxiety
  • hypotension
  • injury
  • rash
50-59:
  • pain
  • renal failure
  • injury
  • anxiety
  • atrial fibrillation
  • dyspnoea
  • oedema peripheral
  • asthenia
  • emotional distress
  • nausea
60+:
  • pain
  • atrial fibrillation
  • renal failure
  • anxiety
  • injury
  • cardiac failure congestive
  • emotional distress
  • dyspnoea
  • hypotension
  • fear

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Amiodarone hydrochloride?

Can you answer these questions?

More questions for: Metoprolol tartrate, Amiodarone hydrochloride

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Amiodarone hydrochloride

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Amiodarone hydrochloride (amiodarone hydrochloride) is often used to treat atrial fibrillation/flutter. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.